| |
 |
Professor Ching-lung Lai, MD, FRCP (Lond), FRCP (Edin), FRCP (Glasgow), FRACP, FHKAM (Med), FHKCP
Chair Professor, Department of Medicine, The University of Hong Kong
Simon K Y Lee Professorship Gastroenterology
Hong Kong, China |
|
| |
| Biography: |
|
| |
| Ching-lung LAI is the Simon K Y Lee Professor in Gastroenterology and the Chair Professor of Medicine and Hepatology at the Department of Medicine, University of Hong Kong, where he has been working since his graduation. For the last three decades he has been extensively involved in research into various aspects of HBV, including hepatocellular carcinoma. |
| |
| He is one of the lead investigators in the pivotal trials of various nucleos(t)ide analogues which have revolutionised the treatment of chronic hepatitis B. He and his colleagues have also been investigating the still emerging field of the natural history of chronic hepatitis B, with findings which have an important bearing on the treatment end-points for chronic hepatitis B. |
| |
| Professor Lai has published over 450 peer-reviewed papers and reviews in international journals. His publications have been widely cited and he is one of top scientists in the field of chronic hepatitis B infection. He was invited to give the Leon Schiff State-of-the-Art Lecture at the 2005 annual meeting of the American Association for the Study of Liver Diseases (AASLD), entitled “The Natural History and Treatment of Chronic Hepatitis B: Consensus and Controversies”. A second edition of the book “Hepatitis B Virus” which Professor Lai co-edited with Professor Stephen Locarnini was published in 2008 by the International Medical Press. He has also been awarded multiple awards by the University of Hong Kong for his outstanding teaching. |
| |
| Session: |
|
| |
| 21st November 2015 (Saturday) |
 |
09:00 – 10:00 |
|
| |
| Session II: Early Clinical Research on Asian Diseases |
| |
| |
| |
| |
| |
|
|
